Eli Lilly Set to Close $2.4B Dice Therapeutics Acquisition to Treat Autoimmune Diseases
Eli Lilly will spend nearly $2.4 billion to acquire Dice Therapeutics to create more drugs to combat autoimmune diseases.
American pharmaceutical company Eli Lilly has announced that it intends to buy biopharmaceutical company Dice…